Page 21 - Sanket Koul

Ujala Cygnus to acquire around 60% stake in Punjab hospital chain

Ujala Cygnus plans to expand further in northern India, to focus on super speciality units

Unsold affordable units drop 19% in top 7 cities in Q1CY25, bucking slump

Luxury segment sees 24% surge in unsold units over robust supply, inventory pile-up

38% rise in notified TB cases in children aged 14 or below in 5 years

Experts indicate Covid effect, malnutrition, rise in drug-resistant TB as major factors

Will money in hand from tax breaks in FY26 make its way to realty buys?

Realty majors hopeful of mid-level housing revival; But experts say education, savings may take priority

Centre, Delhi sign MoU for Rs 2,000 crore health infrastructure mission

Distribution of PMJAY cards begins in Delhi; state govt aims to cover 2.35 lakh families in first phase

CDSCO brings new rules for drugs transfer from SEZ units to domestic mkt

In a circular dated April 8, the CDSCO mandated a new procedure to streamline the transfer of drugs manufactured in SEZs to DTAs for sale and distribution

Booster shot as India's pharma market grew 8.4% in FY25: Pharmarack

Augmentin remains top-selling medicine brand at Rs 816 crore sales

Signature Global Q4 pre-sales booking down 61% over launch approval delays

This comes even as the realty major's pre-sales figure for the overall FY25 rose to Rs 10,290 crore, a 42 per cent increase from Rs 7,270 crore recorded for the entire FY24

India's medtech industry goes local to develop high-end equipment

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)

Delhi joins Ayushman Bharat scheme, 3.6 million people to benefit

Delhi government to initiate card distribution from April 10

From construction sites to factory floor, Indian firms battle heat

For industries like steel manufacturing, where extreme temperatures are part of daily operations, structured heat management protocols are crucial

Indian medical devices industry calls USA's 27% tariff challenge for growth

The new tariffs may impact India's medical devices exports, said Rajiv Nath, forum coordinator for the Association of Indian Medical Device Industry (AiMeD)

CDSCO issues revised risk classification list for cardiovascular devices

Industry stakeholders asked to submit feedback to draft list by April 30

USTR flags hurdles for US med device exports to India before tariff move

Medtech manufacturers' groups expect negotiations may lead to fairer outcomes for both sides

USTR flags barriers for med device export to India ahead of Apr 2 deadline

Move comes even as domestic medtech manufacturers lobby asked GOI to work towards a fair deal

Over 600 private hospitals have opted out of Ayushman Bharat since 2018

Private players say lower rates, delayed dues hampering participation in the scheme

Spurious batch of Telma H flagged, 103 other drugs fail CDSCO tests

Telma H is manufactured by Glenmark Pharmaceuticals and is prescribed for controlling high blood pressure, particularly in individuals prone to water retention or heart failure

Cardiac stents to cost 2% more as regulator allows prices to be raised

National Pharmaceutical Pricing Authority allows manufacturers to make adjustment for inflation

Parl panel flags concerns over CBSE's dual board exam plan for Class 10

In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026

NPPA revises ceiling prices for over 900 drug formulations from April 1

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government